Securities code: 300138 securities abbreviation: Chenguang Biotech Group Co.Ltd(300138) Announcement No.: 2021-161 Chenguang Biotech Group Co.Ltd(300138)
Announcement on capital increase to subsidiary Handan Chenguang
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Overview
The 37th meeting of the 4th board of directors of Chenguang Biotech Group Co.Ltd(300138) (hereinafter referred to as “the company”) deliberated and adopted the proposal on capital increase to the subsidiary Handan Chenguang, in order to meet the requirements of the wholly-owned subsidiary – Chenguang Biotech Group Co.Ltd(300138) Technology Group Handan Co., Ltd. (hereinafter referred to as “Handan Chenguang”) ）In order to meet the needs of the development of business scale, improve its asset liability structure and support the development of new business, the company plans to use its own funds to increase capital by 150 million yuan to Handan Chenguang. After the capital increase, the registered capital of Handan Chenguang will increase to 200 million yuan. This capital increase to the subsidiary does not constitute a related party transaction, nor does it constitute a major asset reorganization specified in the administrative measures for major asset reorganization of listed companies. Within the approval authority of the company’s board of directors, it is not necessary to submit it to the general meeting of shareholders for deliberation.
2、 Basic information of Chenguang in Handan
1. Capital increase method: the company decided to use its own capital of 150 million yuan to increase capital to Handan Chenguang. 2. Handan Chenguang basic information
Company name: Chenguang Biotech Group Co.Ltd(300138) Technology Group Handan Co., Ltd
Address: No. 9, maosui street, Handan Economic Development Zone, Hebei Province
Enterprise type: limited liability company
Legal representative: Wan Haichao
Registered capital: 50 million yuan
Business scope: production and sales of food; Production and sales of health food; Production and sales of plant extracts; Edible vegetable oil sales; Sales of food Shenzhen Agricultural Products Group Co.Ltd(000061) , cosmetics and daily necessities; Shenzhen Agricultural Products Group Co.Ltd(000061) acquisition; Beauty services; Psychological counseling services (excluding medical diagnosis and treatment activities); ticketing services; property services; self owned house and site leasing; food and drug technology research and development, technical consulting, technical services and technology transfer; import and export of goods and technology.
Handan Chenguang is a wholly-owned subsidiary of the company. After the capital increase, the registered capital of Handan Chenguang will increase to 200 million yuan.
The main financial data of Handan Chenguang in the latest year are as follows:
Project on November 30, 2021 or December 31, 2020 or
January November 2021 January December 2020
Total assets (10000 yuan) 25994.5324568.22
Total liabilities (10000 yuan) 239434922507.94
Owner’s equity (10000 yuan) 2051042060.28
Operating income (10000 yuan) 6945953169.02
Total profit (10000 yuan) -9.23-910.37
Net profit (10000 yuan) -9.23-910.37
3、 Purpose, existing risks and impact on the company of this capital increase
The third step of the company’s “three-step” development strategy is to expand and strengthen major health industries such as health products and traditional Chinese medicine extraction, so as to contribute to human health.
Handan Chenguang undertook the construction of “three centers” (R & D center, pilot test center and testing center), health food business, Research Institute of traditional Chinese medicine industry and relevant supporting facilities, which laid the foundation for the “third step” development of the company. By the end of November, the registered capital was 50 million yuan and the amount of non current assets was 188 million yuan (investment amount of fixed assets, construction in progress, intangible assets, etc.), in order to meet its development needs, improve the asset liability structure and support the development of new business, the company plans to use its own funds to increase the registered capital of Handan Chenguang by 150 million yuan. After the completion of this capital increase, the registered capital of Handan Chenguang will increase from 50 million yuan to 200 million yuan.
Handan Chenguang is a wholly-owned subsidiary of the company. After the capital increase, the scope of consolidated statements will not be changed and will not have an impact on the financial situation of the company. Subsequently, the company will issue a progress announcement according to the progress of capital increase.
4、 Documents for future reference
1. Resolution of the 37th meeting of the 4th board of directors
2. Handan Chenguang basic data
It is hereby announced
Chenguang Biotech Group Co.Ltd(300138) board of directors December 26, 2021
